Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
Ribosomopathies encompass a spectrum of disorders arising from impaired ribosome biogenesis and reduced functionality. Mutation or dysexpression of the genes that disturb any finely regulated steps of ribosome biogenesis can result in different types of ribosomopathies in clinic, collectively known...
שמור ב:
| Principais autores: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-03-01
|
| סדרה: | Journal of Pharmaceutical Analysis |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2095177923002599 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|